Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

100.76
-0.1300-0.13%
Post-market: 100.760.00000.00%19:30 EDT
Volume:92.51K
Turnover:9.33M
Market Cap:4.14B
PE:-97.99
High:101.63
Open:101.54
Low:100.57
Close:100.89
52wk High:107.69
52wk Low:85.36
Shares:41.10M
Float Shares:41.10M
Volume Ratio:0.86
T/O Rate:0.23%
Dividend:1.44
Dividend Rate:1.43%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.07
PE(LYR):-97.99

Loading ...

UnitedHealth to Present Strategy at Wells Fargo Conference

TIPRANKS
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09

Headlands Research Names Brandon Pallott Chief Commercial Officer

Reuters
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

TIPRANKS
·
Sep 09

Option traders moderately bearish in UnitedHealth with shares down 1.28%

TIPRANKS
·
Sep 08

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Dow Jones
·
Sep 08

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

GlobeNewswire
·
Sep 08

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Reuters
·
Sep 08

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

GlobeNewswire
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Stock News
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Bluejay Diagnostics and Lovell Government partner to access federal healthcare

TIPRANKS
·
Sep 08

Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00

THOMSON REUTERS
·
Sep 08

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Sep 08